PSA leads accreditation charge
After the announcement of the AACP closure, Australian Pharmacist examines why PSA has and always will be the home of accreditation.
Artificial Intelligence – real opportunities
Artificial intelligence promises to upend entire industries and pharmacy is far from immune – here’s how AI can remake drug discovery, customer service, training...
Breathing new life into COPD diagnosis and treatment
Prevention, early diagnosis and optimal treatment are essential to reduce the progression of this irreversible disease.
Addressing Australia’s overdose problem
For the fifth year in a row, more than 2,000 Australians lost their lives to overdose in 2018, according to Australia’s Annual Overdose Report 2020 from Penington Institute.
How pharmacists can help with pain relief
Senior pharmacists share latest updates on best practice in pain relief for fever in children, osteoarthritis and in older people with comorbidities.
The cardiovascular crisis needs a pharmacy-led response
Pharmacists have numerous opportunities to assess risk, recommend therapies, and help patients manage their heart health.













